Supply of Belimumab (DOE)

This tender concerns the supply of Belimumab, a biologic medication used in the treatment of certain autoimmune diseases. Belimumab is a monoclonal antibody that targets B-lymphocyte stimulator (BLyS), a protein involved in the survival and maturation of B cells. By inhibiting BLyS, Belimumab reduces the activity of B cells that contribute to autoimmune conditions.

The specific details regarding the quantity, dosage forms, packaging, and delivery timelines for the Belimumab supply will be outlined in the full tender documentation. Bidders are expected to demonstrate their capability to provide a reliable and consistent supply of this pharmaceutical product, adhering to all relevant quality standards and regulatory requirements for medicinal products. This may include evidence of Good Manufacturing Practices (GMP) compliance and appropriate storage and transportation conditions to maintain product integrity.

Interested parties should review the complete tender package for comprehensive information on eligibility criteria, submission procedures, evaluation methodologies, and contractual terms. The procurement aims to ensure the availability of Belimumab for patients requiring this specific therapy, likely within a healthcare system or for distribution to medical facilities. Potential suppliers should be prepared to provide detailed technical specifications and potentially samples of the product as part of their bid. The tender is open to qualified pharmaceutical suppliers with the necessary licenses and experience in handling and distributing specialized biological drugs.

This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Pharmaceuticals. Located in Spain, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.